New QCDR Measures Available for 2021 Reporting
AQI NACOR Qualified Clinical Data Registry (QCDR) participants have the opportunity to report new quality measures for the 2021 MIPS performance year. In addition to CMS approving AQI NACOR as a QCDR, the agency also approved AQI NACOR to report these measures on behalf of their participants: - ePreop31: Intraoperative Hypotension among Non-Emergent Noncardiac Surgical Cases
- AQI69: Intraoperative Antibiotic Redosing
- AQI70: Prevention of Arterial Line-Related Bloodstream Infections
- AQI71: Ambulatory Glucose Management
- AQI72: Perioperative Anemia Management
Over the course of the reporting year, the ASA Committee on Performance and Outcomes Measurement (CPOM) reviews available quality measures and recommends their inclusion in the AQI NACOR QCDR. In 2020, CPOM worked with the Intraoperative Hypotension measure developer and steward to amend the measure in a way that should make reporting easier and more meaningful for individuals and groups. An internal improvement measure in 2020, CPOM felt that the changes made to the measure in 2020 allowed for the measure to be promoted to a QCDR measure this year. As indicated, ePreop31 was amended to remove MAC anesthesia and include regional and neuraxial anesthesia. In addition, denominator exclusions were expanded to include ASA physical status 1 and intentional hypotension. Last, the hypotension measure risk adjustment was changed to take into more clear consideration of surgical complexity. For information on how to start reporting this new QCDR measure, visit https://www.provationmedical.com/ioh/. The other four measures, indicated by AQI69, AQI70, AQI71, and AQI72, were developed by CPOM during the 2019-2020 governance year. In 2020, CPOM released its report that detailed how the measures were developed and the public comments that the measures received. That report is available on the ASA website for member reference. ASA and AQI worked closely with our QCDR partners to gather preliminary data on these measures. Although these measures have been approved for 2021, CMS requires that a minimum number of physicians and groups report the measures each year for the measures to remain in the program. Groups wishing to diversify their scoring in the MIPS performance category may wish to test and/or report these measures for the 2021 reporting year. Quality benchmarks on the four new measures will be based upon data submitted for the 2021 performance year. Contact ASA Quality and Regulatory Affairs (QRA) at qra@asahq.org for questions on reporting these measures.
|